ImmunoPET of CD146 in Orthotopic and Metastatic Breast Cancer Models.
Journal
Bioconjugate chemistry
ISSN: 1520-4812
Titre abrégé: Bioconjug Chem
Pays: United States
ID NLM: 9010319
Informations de publication
Date de publication:
21 07 2021
21 07 2021
Historique:
pubmed:
22
1
2021
medline:
15
12
2021
entrez:
21
1
2021
Statut:
ppublish
Résumé
The overexpression of CD146 in breast cancer is considered a hallmark of tumor progression and metastasis, particularly in triple negative breast cancer. Aimed at imaging differential CD146 expressions in breast cancer, a noninvasive method for predictive prognosis and diagnosis was investigated using a
Identifiants
pubmed: 33475350
doi: 10.1021/acs.bioconjchem.0c00649
pmc: PMC8292437
mid: NIHMS1674629
doi:
Substances chimiques
CD146 Antigen
0
MCAM protein, human
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1306-1314Subventions
Organisme : NCI NIH HHS
ID : P30 CA014520
Pays : United States
Références
Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2169-2179
pubmed: 27342417
Oncotarget. 2017 Nov 28;8(68):112283-112296
pubmed: 29348825
J Nucl Med. 2021 Mar;62(3):372-378
pubmed: 32826320
J Cell Physiol. 2018 Jul;233(7):5200-5213
pubmed: 29219189
CA Cancer J Clin. 2020 Jan;70(1):7-30
pubmed: 31912902
Nature. 2012 Oct 4;490(7418):61-70
pubmed: 23000897
Am J Nucl Med Mol Imaging. 2019 Dec 15;9(6):296-308
pubmed: 31976159
J Clin Oncol. 2012 Nov 1;30(31):3884-92
pubmed: 22987087
J Nucl Med. 2017 Jan;58(1):162-168
pubmed: 27493273
Oncotarget. 2016 Apr 26;7(17):24677-87
pubmed: 27013581
Cancer Lett. 2017 Feb 1;386:65-76
pubmed: 27838413
Breast Cancer Res. 2009;11(1):R1
pubmed: 19123925
Front Chem. 2014 Dec 18;2:112
pubmed: 25566530
Nucl Med Commun. 2016 Nov;37(11):1116-24
pubmed: 27438531
J Nucl Med. 2016 Oct;57(10):1523-1528
pubmed: 27151988
Cureus. 2016 Dec 28;8(12):e945
pubmed: 28133583
Am J Nucl Med Mol Imaging. 2018 Oct 20;8(5):341-350
pubmed: 30510851
Am J Nucl Med Mol Imaging. 2019 Feb 15;9(1):12-23
pubmed: 30911434
ChemMedChem. 2018 Dec 6;13(23):2466-2478
pubmed: 30246488
Adv Sci (Weinh). 2019 Feb 27;6(9):1801237
pubmed: 31065511
Cancers (Basel). 2018 May 05;10(5):
pubmed: 29734758
Breast Cancer Res Treat. 2018 Jun;169(3):523-530
pubmed: 29442264
Proc Natl Acad Sci U S A. 2015 Nov 24;112(47):E6525-34
pubmed: 26553993
Cancer Res. 2017 Aug 15;77(16):4414-4425
pubmed: 28646020
Mol Pharm. 2016 Jul 5;13(7):2563-70
pubmed: 27280694
Theranostics. 2016 Aug 08;6(11):1918-33
pubmed: 27570560
J Vis Exp. 2014 Nov 20;(93):e52099
pubmed: 25490604
Science. 2013 Feb 1;339(6119):580-4
pubmed: 23372014
Circ Res. 2010 Jul 9;107(1):66-75
pubmed: 20448216
Eur J Nucl Med Mol Imaging. 2018 Jul;45(8):1372-1381
pubmed: 29450576
Am J Nucl Med Mol Imaging. 2020 Jun 15;10(3):135-142
pubmed: 32704404
IEEE Trans Ultrason Ferroelectr Freq Control. 2015 Apr;62(4):637-46
pubmed: 25881342
Int J Cancer. 2020 Jul 15;147(2):490-504
pubmed: 32020593